KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) Net Margin (2016 - 2026)

Idexx Laboratories has reported Net Margin over the past 17 years, most recently at 22.76% for Q4 2025.

  • For Q4 2025, Net Margin rose 11.0% year-over-year to 22.76%; the TTM value through Dec 2025 reached 24.62%, up 184.0%, while the annual FY2025 figure was 24.62%, 184.0% up from the prior year.
  • Net Margin for Q4 2025 was 22.76% at Idexx Laboratories, down from 24.85% in the prior quarter.
  • Over five years, Net Margin peaked at 26.5% in Q2 2025 and troughed at 15.34% in Q2 2022.
  • A 5-year average of 22.76% and a median of 23.18% in 2022 define the central range for Net Margin.
  • Biggest five-year swings in Net Margin: plummeted -910bps in 2022 and later soared 843bps in 2023.
  • Year by year, Net Margin stood at 20.32% in 2021, then increased by 2bps to 20.78% in 2022, then rose by 4bps to 21.58% in 2023, then grew by 5bps to 22.65% in 2024, then increased by 0bps to 22.76% in 2025.
  • Business Quant data shows Net Margin for IDXX at 22.76% in Q4 2025, 24.85% in Q3 2025, and 26.5% in Q2 2025.